{"id":"2f63694c-8e3a-4776-b912-815fc63ccd2f","kind":"news","code":"2f63694c-8e3a-4776-b912-815fc63ccd2f","name":"Xiangshang Biotechnology completes seed financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"享熵生物完成种子轮融资","eventDate":"2025-05-13T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:30:29.931Z","englishUpdatedAt":"2026-10-15T18:29:25.332Z","reviewedAt":"2026-10-15T18:29:25.332Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7860445366b526626b41f796d0a18fb972bdeccc00a7f0a6812d948dd06682c2","companyId":"87719371-8e40-41e6-be8b-0fe3310fea5e","foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"87719371-8e40-41e6-be8b-0fe3310fea5e","kind":"companies","code":"UB-C6529","name":"Xiangshang Biotechnology","nameBasis":"transliterated","summary":"Developing high-performance industrial enzymes, specialty enzymes, and pharmaceutical and health ingredients through AI enzyme design and directed evolution","description":"","country":"China","category":null,"originalName":"享熵生物","eventDate":null,"website":"https://evoxentro.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:25:20.716Z","reviewedAt":"2026-10-20T18:25:20.716Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"cde56e48584eeedb9637264e97aa38493a5e186cefa2081308b91bcfe8c16c89","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/UB-C6529"},{"id":"48e189c6-a99e-4103-a871-1834c60f6844","kind":"institutions","code":"UB-I1830","name":"Yizhan Capital","nameBasis":"transliterated","summary":"Yizhan Capital is a Chinese venture capital firm investing in seed-stage to startup-stage companies.","description":"Yizhan Capital is a Chinese venture capital firm investing in seed-stage to startup-stage companies.","country":null,"category":null,"originalName":"一盏资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:34:29.305Z","englishUpdatedAt":"2026-10-15T21:21:01.647Z","reviewedAt":"2026-10-15T21:21:01.647Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7ece5ef33f57e976c385f2617c9160ebd4de14ce47a04f4b3ad0a7b26ac499cc","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/yizhan-capital"}],"path":"/news/2f63694c-8e3a-4776-b912-815fc63ccd2f","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Xiangshang Biotechnology","path":"/companies/UB-C6529"}},"canonical":"https://uniquebase.ai/news/2f63694c-8e3a-4776-b912-815fc63ccd2f"}